These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 3923108)
1. Cellular distribution of the Ia-associated chondroitin sulfate proteoglycan. Sant AJ; Schwartz BD; Cullen SE J Immunol; 1985 Jul; 135(1):408-15. PubMed ID: 3923108 [TBL] [Abstract][Full Text] [Related]
2. Biosynthetic relationships of the chondroitin sulfate proteoglycan with Ia and invariant chain glycoproteins. Sant AJ; Cullen SE; Schwartz BD J Immunol; 1985 Jul; 135(1):416-22. PubMed ID: 3858382 [TBL] [Abstract][Full Text] [Related]
3. Murine thymocyte and splenocyte Ia antigens are indistinguishable by two-dimensional gel electrophoresis. Osborne BA; Rudikoff S J Immunol; 1983 Sep; 131(3):1386-90. PubMed ID: 6604097 [TBL] [Abstract][Full Text] [Related]
4. Xyloside inhibits synthesis of the class II-associated chondroitin sulfate proteoglycan and antigen presentation events. Rosamond S; Brown L; Gomez C; Braciale TJ; Schwartz BD J Immunol; 1987 Sep; 139(6):1946-51. PubMed ID: 3497984 [TBL] [Abstract][Full Text] [Related]
5. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1. Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976 [TBL] [Abstract][Full Text] [Related]
6. The human Ia-associated invariant chain is synthesized in Ia-negative B cell variants and is not expressed on the cell surface of both Ia-negative and Ia-positive parental cells. Accolla RS; Carra G; Buchegger F; Carrel S; Mach JP J Immunol; 1985 May; 134(5):3265-71. PubMed ID: 3872331 [TBL] [Abstract][Full Text] [Related]
7. Invariant chain is the core protein of the Ia-associated chondroitin sulfate proteoglycan. Sant AJ; Cullen SE; Giacoletto KS; Schwartz BD J Exp Med; 1985 Dec; 162(6):1916-34. PubMed ID: 3864916 [TBL] [Abstract][Full Text] [Related]
8. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells. Spiro RC; Sairenji T; Humphreys RE J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614 [TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of Ia alloantigens in guinea pigs. I. Synthesis of Ia antigens by subsets enriched for B cells, T cells, or macrophages. Lyons CR; Lipscomb MF; Schlossman SF; Tucker TF; Uhr JW J Immunol; 1981 Nov; 127(5):1879-85. PubMed ID: 6170677 [TBL] [Abstract][Full Text] [Related]
10. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells. Green WR J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998 [TBL] [Abstract][Full Text] [Related]
11. T lymphocyte-dependent B lymphocyte proliferative response to antigen. II. Induction of polyclonal B lymphocyte activation of normal B cells and of Lyb-5- B cells from xid mice via recognition of self-IA antigens. Tse HY; Kanamori S; Mond JJ J Immunol; 1984 Oct; 133(4):1792-800. PubMed ID: 6206138 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin. Mond JJ; Seghal E; Kung J; Finkelman FD J Immunol; 1981 Sep; 127(3):881-8. PubMed ID: 6790620 [TBL] [Abstract][Full Text] [Related]
13. Functional studies on B cell hybridomas with B cell surface antigens. II. Ia molecules on the cell membrane and the differentiative response to anti-mu antibody. Hamano T; Leiserson WM; Asofsky R J Immunol; 1983 Jul; 131(1):98-102. PubMed ID: 6408183 [TBL] [Abstract][Full Text] [Related]
14. [Analysis of the murine autologous mixed lymphocyte reaction. I. Characterization of the stimulator cells and their recognition sites]. Ishida Y Hokkaido Igaku Zasshi; 1982 Sep; 57(5):614-23. PubMed ID: 6983996 [TBL] [Abstract][Full Text] [Related]
15. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones. Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760 [TBL] [Abstract][Full Text] [Related]
16. Secreted and cellular proteochondroitin sulfates of a human B lymphoblastoid cell line contain different protein cores. Butz H; Stuhlsatz HW; Maier G; Schwartz-Albiez R J Biol Chem; 1992 Feb; 267(5):3402-8. PubMed ID: 1737794 [TBL] [Abstract][Full Text] [Related]
17. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells. Callahan GN J Immunol; 1984 May; 132(5):2649-57. PubMed ID: 6201554 [TBL] [Abstract][Full Text] [Related]
18. Endogenous synthesis of Ia antigens by a cloned T cell line. Singh SK; Abramson EJ; Krco CJ; David CS J Mol Cell Immunol; 1984; 1(3):147-56. PubMed ID: 6336592 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody. Ryan JJ; Mond JJ; Finkelman FD; Scher I J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106 [TBL] [Abstract][Full Text] [Related]
20. Ia antigens and associated invariant chain are induced simultaneously in lines of T-dependent mast cells by recombinant interferon-gamma. Koch N; Wong GH; Schrader JW J Immunol; 1984 Mar; 132(3):1361-9. PubMed ID: 6420464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]